What are risk factors for transfusion GVHD?

The risk of TA-GVHD is highest in recipients who are severely immunocompromised, such as those undergoing hematopoietic stem cell transplantation, receiving immunosuppressive therapy, or having congenital immunodeficiencies. Irradiation of blood products can mitigate this risk by inactivating donor T cells.